Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Samar, Ojaimi"'
Autor:
Fiona James, BBiomedSci, Michelle S. Goh, MBBS, Sara Vogrin, MBiostat, Irvin Ng, PhD, Abby P. Douglas, PhD, Natasha E. Holmes, PhD, Kyra YL. Chua, PhD, Joseph De Luca, MBBS, Pooja Sharma, MD, Celia Zubrinich, MPhil, Ar K. Aung, MBBS, Douglas Gin, MBBS, Belinda Lambros, MAdvNursPrac, Chris Baker, MBBS, Peter Foley, MD, Alvin H. Chong, MMed, Francis Thien, MD, Jie S. Fok, MBBS, John Su, MBBS, Laura Scardamaglia, MBBS, Andrew Awad, MD, Steven Tong, PhD, Douglas Johnson, PhD, Jack Godsell, MBBS, Alexis Arasu, MBBS, Sara Barnes, MBA, Samar Ojaimi, PhD, Adrian Mar, MBBS, James Yun, PhD, Nikhita Ange, MBBCh, Winnie W.Y. Tong, PhD, Andrew Carr, DSc, Jacqueline Loprete, PhD, Constance H. Katelaris, PhD, Dana Slape, MBBS, Karuna Keat, MBBS, Timothy A. West, MBBS, Monique Lee, MBBS, William Smith, PhD, Pravin Hissaria, MD, Shireen Sidhu, MBBS, Sonja Janson, MBBS, Sudharsan Venkatesan, MBBS, Jane Davies, PhD, Michael J. Lane, MBBS, Andrew M. Redmond, MBBS, Ivan Robertson, MBBS, Amy Legg, GradDipClinPharm, Suran Fernando, PhD, Therese Boyle, MA, Jamma Li, MPhil, Elizabeth J. Phillips, MD, Heather Cleland, MBBS, Johannes S. Kern, MD, Jason A. Trubiano, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 8, Pp 100936- (2024)
Background: Severe cutaneous adverse reactions (SCAR) are a group of delayed presumed T-cell mediated hypersensitivities associated with significant morbidity and mortality. Despite their shared global healthcare burden and impact, the clinical pheno
Externí odkaz:
https://doaj.org/article/8c77fdb91b8d4d9fa601e0c6ab0c13db
Autor:
Anita J. Campbell, Shakeel Mowlaboccus, Geoffrey W. Coombs, Denise A. Daley, Laila S. Al Yazidi, Linny K. Phuong, Clare Leung, Emma J. Best, Rachel H. Webb, Lesley Voss, Eugene Athan, Philip N. Britton, Penelope A. Bryant, Coen T. Butters, Jonathan R. Carapetis, Natasha S. Ching, Joshua Francis, Te-Yu Hung, Clare Nourse, Samar Ojaimi, Alex Tai, Nan Vasilunas, Brendan McMullan, Asha C. Bowen, Christopher C. Blyth
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 197-206 (2022)
Objectives: The role Staphylococcus aureus antimicrobial resistance genes and toxins play in disease severity, management and outcome in childhood is an emerging field requiring further exploration. Methods: A prospective multisite study of Australia
Externí odkaz:
https://doaj.org/article/fe7cbfbe2da84ef0aff55360884b834f
Autor:
Gemma E Hartley, Emily S J Edwards, Julian J Bosco, Samar Ojaimi, Robert G Stirling, Paul U Cameron, Katie Flanagan, Magdalena Plebanski, Philip Mark Hogarth, Robyn E O’Hehir, Menno C vanZelm
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 10, Pp n/a-n/a (2020)
Abstract Background Annual influenza vaccination is recommended to all individuals over 6 months of age, including predominantly antibody deficiency (PAD) patients. Vaccination responses are typically evaluated by serology, and because PAD patients a
Externí odkaz:
https://doaj.org/article/735b1e7014794777a7f6c1fbad0307d2
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 12, Pp 2894-2899 (2018)
Objective: To evaluate quality of patient knowledge and rates of adherence to guidelines amongst splenectomised patients registered to the Spleen Australia registry. Method: Registrants recruited for assessment of residual splenic function post-splen
Externí odkaz:
https://doaj.org/article/e8b04de21d4049eeaa823eec0bef79b6
Autor:
Leisa Rebecca Watson, Charlotte A. Slade, Samar Ojaimi, Sara Barnes, Pasquale Fedele, Prudence Smith, Justine Marum, Sebastian Lunke, Zornitza Stark, Matthew F. Hunter, Vanessa L. Bryant, Michael Sze Yuan Low
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-5 (2018)
Abstract Background Daclizumab is a humanized monoclonal antibody that blocks CD25, the high affinity alpha subunit of the interleukin-2 receptor. Daclizumab therapy targets T regulatory cell and activated effector T cell proliferation to suppress au
Externí odkaz:
https://doaj.org/article/a9a5213b08cb415fa5b05e82cef8b2f1
Publikováno v:
Rheumatology. 62:1248-1253
Objectives Autoantibodies to ENA are frequently ordered during the workup of suspected autoimmune connective tissue diseases. There are no current guidelines for repeat test ordering. The objective of this study was to assess the utility of repeat EN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::673dc29d31d5c9073e56ee5d6b6dc286
https://doi.org/10.1093/rheumatology/keac437
https://doi.org/10.1093/rheumatology/keac437
Autor:
Emily S.J. Edwards, Samar Ojaimi, James Ngui, Go Hun Seo, JiHye Kim, Sanjeev Chunilal, Deborah Yablonski, Robyn E. O’Hehir, Menno C. van Zelm
Publikováno v:
Journal of Allergy and Clinical Immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e87de790e9aa83b2e0fc4953bab2f5e
https://doi.org/10.1016/j.jaci.2023.04.020
https://doi.org/10.1016/j.jaci.2023.04.020
Autor:
Grace I. Butel-Simoes, Penelope Jones, Erica M. Wood, Denis Spelman, Ian J. Woolley, Samar Ojaimi
Publikováno v:
Annals of Hematology. 101:1421-1434
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d5d5d09239302fd5cf779565445dcc3
https://doi.org/10.1007/s00277-022-04765-3
https://doi.org/10.1007/s00277-022-04765-3
Autor:
David Egg, Charlotte Schwab, Annemarie Gabrysch, Peter D. Arkwright, Edmund Cheesman, Lisa Giulino-Roth, Olaf Neth, Scott Snapper, Satoshi Okada, Michel Moutschen, Philippe Delvenne, Ann-Christin Pecher, Daniel Wolff, Yae-Jean Kim, Suranjith Seneviratne, Kyoung-Mee Kim, Ji-Man Kang, Samar Ojaimi, Catriona McLean, Klaus Warnatz, Maximilian Seidl, Bodo Grimbacher
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Background: Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is a negative immune regulator on the surface of T cells. In humans, heterozygous germline mutations in CTLA4 can cause an immune dysregulation syndrome. The phenotype comprises a broad
Externí odkaz:
https://doaj.org/article/27f24119d6174f2ba0ac828f55c874a1
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
The dwindling list of antimicrobial agents exhibiting broad efficacy against clinical strains of Mycobacterium tuberculosis (Mtb) has forced the medical community to redefine current approaches to the treatment of tuberculosis (TB). Host receptor-int
Externí odkaz:
https://doaj.org/article/0ae63a5103ed496087a8539831b016f6